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Abstract
Perfluoroalkyl substances (PFAS), found in many household products and classed as endocrine 
disrupting chemicals, can be transferred through the placenta and are associated with multiple 
developmental deficits in offspring. Using data from the Avon Longitudinal Study of Parents and 
Children (ALSPAC), we investigated the association between intrauterine exposure to PFAS and 
early communication development in 432 mother-daughter dyads at 15 and 38 months of age. 
Concentrations of perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), perfluorohexane 
sulfonate (PFHxS), and perfluorononanoate (PFNA) were measured in maternal serum collected 
during pregnancy. Early communication development was measured with the ALSPAC-adapted 
MacArthur Communicative Development Inventories for Infants and Toddlers. The infant 
questionnaire measured verbal comprehension, vocabulary comprehension and production, 
nonverbal communication, and social development. The toddler questionnaire measured language, 
intelligibility, and communicative subscores. Multivariable linear regression was used to examine 
associations between each PFAS exposure and each communication sub-scale score. The 
association between maternal PFAS concentrations and early communication development at 15 
and 38 months of age varied by maternal age at delivery. In daughters of younger mothers (< 25 
years of age), every 1 ng/mL of PFOS was associated with a 3.82 point (95% confidence interval 
(CI): −6.18, −1.47) lower vocabulary score at 15 months and a 0.80 point (95% CI: −1.74, 0.14) 
lower language score at 38 months. Prenatal exposure to select PFAS was positively and 
negatively associated with communication development among girls, with inconsistent pattern of 
association across all measured PFAS and endpoints.
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1. Introduction
Perfluoroalkyl substances (PFAS) comprise a class of man-made endocrine disrupting 
chemicals (EDCs) involved in the production of fluoropolymers found in many household 
consumer products. PFAS are used to make protective coatings on textiles, furniture, food 
packaging, and nonstick cookware. Exposure to PFAS is common and can occur through 
water, indoor dust, and air [1]. PFAS are found in circulating blood, breastmilk, cord blood 
and can be transferred through the penetrable placenta during pregnancy [2–4]. The most 
commonly studied PFAS include perfluorooctane sulfonate (PFOS), perfluorooctanoate 
(PFOA), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA).
The risk of potential adverse health effects from PFAS has led to an industry phase out and 
replacement of some of these chemicals in the U.S. and Europe; however, PFOS is still 
commonly manufactured in China [5–7]. PFAS are a public health concern due to their 
persistent nature and ability to bioaccumulate in body tissue [5,8–10]. The estimated mean 
serum elimination half-life for PFOS, PFOA, and PFHxS is 5.4, 3.8, and 8.5 years, 
respectively [11].
Evidence suggests that prenatal exposure to various EDCs may be associated with certain 
cognitive and behavioral problems in childhood [12–17]. A fetus can be susceptible to 
developmental effects of PFAS associated with disruption of estrogenic activity [18,19].
PFOS and PFOA exposure during critical windows of development can affect 
neurodevelopment of a pregnant mother's offspring. In mice, neonatal PFOS and PFOA 
exposure causes altered levels of essential proteins needed for brain development, 
specifically affecting the hippocampus, which is primarily responsible for memory and 
learning [20]. In humans, the association between prenatal PFAS exposure and early 
cognitive development is unclear. A cross sectional analysis of data from the U.S. National 
Health and Nutrition Examination Survey (NHANES) has demonstrated that higher 
exposure to PFAS is associated with an increased odds of attention deficit/hyperactivity 
disorder (ADHD) in children 12–15 years of age [13]. However, two previous reports from 
the Taiwan Birth Panel Study and the Danish National Birth Cohort, have found inconsistent 
associations between prenatal PFOS and PFOA exposure and neurodevelopment. 
Specifically, using mother-reported structured questionnaires for children at 6 and 18 months 
of age, the Danish National Birth Cohort did not find a significant association between 
prenatal PFOS or PFOA exposure and neurodevelopment [21]. In contrast, using 
Comprehensive Development Inventory for Infants and Toddlers at 2 years of age, the 
Taiwan Birth Panel Study concluded that prenatal exposure to PFOS and PFOA may be 
negatively associated with neurodevelopment in children [12]. Additional research using 
longitudinal biomarker and cognitive function data to evaluate the association between early 
life exposure to PFAS and cognitive development in young children is warranted [22].
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The current study aimed to investigate whether maternal concentrations of PFOS, PFOA, 
PFHxS, and PFNA during pregnancy was associated with deficits in development of 
communication skills at 15 and 38 months of age in British girls using data from the Avon 
Longitudinal Study of Parents and Children (ALSPAC). We also examined whether the 
association between maternal PFAS exposure and communication development varied by 
maternal age at delivery or maternal education. Data used for this study was originally 
selected for a nested case-control study examining environmental effects on menarche [23].
2. Methods
2.1. Study Population
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort that 
recruited pregnant women with expected delivery dates between April 1991 and December 
1992 in three health districts of the former Avon region, Great Britain. The study enrolled 
14,541 pregnant women and 14,062 children at birth. Recruitment methods have been 
described previously [24]. During pregnancy, mothers provided blood samples and 
participated in clinical assessments and questionnaires. Offspring have been followed since 
birth through completion of clinical assessments and questionnaires designed to assess 
environmental and genetic factors affecting health and development. The study website 
contains additional details for all available data through a fully searchable data dictionary 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
The present study used data from 448 mother-daughter dyads originally identified to 
participate in a nested case-control study to assess associations between prenatal EDC 
exposure and timing of menarche [23]. Cases and controls were chosen among all girls 
within the ALSPAC cohort who returned at least two puberty questionnaires between the 
ages of 8 and 13 years. Cases were defined as girls who attained menarche before 11.5 years 
and controls were defined as a random sample of girls who attained menarche at or after 
11.5 years of age. Among the 448 mother-daughter dyads, 432 had measured maternal 
gestational blood concentrations for all studied PFAS and completed either the ALSPAC-
adapted MacArthur Communicative Development Inventories (MCDI) for Infants at 15 
months, the ALSPAC-adapted MCDI for Toddlers at 38 months, or both. Ethical approval 
for the study was obtained from the ALSPAC Ethics and Law Committee, the Local 
Research Ethics Committees, and the Centers for Disease Control and Prevention (CDC) 
Institutional Review Board. Mothers provided written informed consent for participation in 
the study.
2.2. Data collection
An adaptation of the MCDI was used to assess early communication development at 15 and 
38 months. The ALSPAC adaptation of the MCDI includes a selection of questions from the 
original MCDI and was modified to include words used in England. The MCDI is a parent 
reported questionnaire originally developed for clinicians to assess early language, non-
verbal, and social development in children. The MCDI can be used to identify children with 
low language skills, and can potentially be useful in the assessment of children with autism 
spectrum disorders (ASD) [25,26]. Previous research has demonstrated that the MCDI 
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assessment administered at 2 and 3 years of age can be used to predict developmental delays 
later in childhood [27].
At both time points, the MCDI questionnaire was completed by the mother and was returned 
via mail. At 15 months, the infant questionnaire generated 4 derived communication sub-
scores (range of score): verbal comprehension (0−12), vocabulary comprehension and 
production (0–268), nonverbal communication (0−20), and social development (0−32). At 
38 months, the toddler questionnaire generated 3 sub-scores (range of score): language (8–
326), intelligibility (0–6), and communicative (4–12). The language sub-score at 38 months 
combines vocabulary, plurals, past tense, and word combination scores. Each increment of 
the score corresponds to a specific question or degree of communication development 
relating to the sub category. A higher sub-score indicates greater communication 
development.
Covariates were collected from medical records and questionnaires. Potential effect 
modifiers included maternal age at delivery (in years) and maternal education (< O level, O 
level, > O level). Potential confounders included parity (none, 1 or more); maternal smoking 
status during the first three months of pregnancy (any, none); maternal alcohol use during 
the first three months of pregnancy (any, none); adaptation of the Crown-Crisp Experiential 
Index (CCEI), an indicator of maternal anxiety, depression, and somaticism at 8 months 
postdelivery (continuous); and gestational age when the serum sample was collected (in 
weeks).
2.3. Laboratory Analysis
Concentrations of PFOS, PFOA, PFHxS, and PFNA were measured from maternal serum 
samples collected during pregnancy at a median gestational age of 15 weeks. Maternal 
serum concentrations were used as a proxy for fetal exposure. Blood samples were 
transferred under controlled conditions to the National Center for Environmental Health of 
the Centers for Disease Control and Prevention in the United States for analysis. A previous 
study has described methods used to measure analytes in the serum samples [28]. Limits of 
detection were 0.2 ng/mL for PFOS, 0.1 ng/mL for PFOA, 0.1 ng/mL for PFHxS, and 0.08 
ng/mL for PFNA. Quality control measures to ensure calibration were implemented using 
standards, reagent blanks, and study samples. Precision of measurements for the analytes, as 
relative standard deviation, ranged from 8 to 13%.
2.4. Statistical analysis
To investigate the association between maternal PFAS concentrations and each early 
communication sub-score, stratum-weighted linear regression models were developed with 
the communication measures and PFAS concentrations as continuous variables. Crude 
associations between PFAS analytes and early communication development scores were first 
examined using univariate regression analysis. A set of potential confounding variables was 
selected a priori for consideration in multivariable regression models. The final model was 
achieved through backwards elimination of insignificant variables in a hierarchical manner 
[29]. The following variables were controlled for in the final model: parity, maternal age, 
maternal education, maternal smoking status during the first three months of pregnancy, and 
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gestational age at which the sample was collected. Analyses at 38 months also controlled for 
total CCEI score. Maternal alcohol consumption status during the first three months of 
pregnancy was considered as a potential confounder but not included in the final model 
because of lack of statistical significance. Maternal age and maternal education were 
selected a priori to be evaluated for effect modification with PFAS variables by testing 
appropriate cross-product interaction terms. To account for the original nested case-control 
study design, we weighted the sample to adjust for under-representation of the true number 
of girls without early menarche (weight for cases was 1 and for controls was 15.1). All 
statistical tests were 2-tailed; a p-value < 0.05 was considered statistically significant. SAS 
version 9.2 (SAS Institute Inc., Cary, NC) was used to conduct all analyses.
3. Results
Table 1 presents demographic characteristics for 432 mother-daughter dyads included in our 
analysis. PFAS were detected in all maternal serum samples with PFOS present at the 
highest concentration, followed by PFOA, PFHxS, and PFNA (Table 1). Pearson correlation 
coefficients among the PFAS ranged from 0.69 for PFOS and PFHxS to 0.11 for PFNA and 
PFHxS, and coefficients between communication development outcomes at 15 and 38 
months ranged from 0.34 for social development at 15 months and language development at 
38 months and 0.02 for verbal comprehension at 15 months and intelligibility at 38 months 
(data not shown).
In the overall adjusted main effect models at 15 months of age (Table 2), positive 
associations were seen between PFOS, PFOA, PFHxS, and PFNA maternal concentrations 
and daughters' verbal comprehension, vocabulary comprehension and production, and 
nonverbal communication. The association between maternal PFAS concentrations and early 
communication development varied by maternal age at delivery. After stratification for 
maternal age at delivery, positive and negative associations were found by maternal age 
between maternal PFAS concentrations and vocabulary comprehension and production. For 
daughters whose mothers were < 25 years of age at the time of delivery, vocabulary score 
was 3.82 points (95% confidence interval (CI): −6.18, −1.47) lower for every ng/mL of 
PFOS, 11.39 points (95% CI: −22.76, −0.02) lower for every ng/mL of PFOA, 16.26 points 
(95% CI: −36.79, 4.27) lower for every ng/mL of PFHxS, and 36.29 (95% CI: −79.51, 6.92) 
points lower for every ng/mL of PFNA. In contrast, for daughters whose mothers were over 
30 years of age, positive associations were observed between all measured PFAS and 
vocabulary score.
In the overall adjusted main effect models at 38 months of age (Table 3), positive and 
negative associations were seen between measured maternal PFAS concentrations and 
language, intelligibility, and communicative scores. For every ng/mL of PFOS, language 
score was lower by 0.29 point (95% CI: −0.54, −0.06) and intelligibility score was lower by 
0.01 point (95% CI: −0.01, 0.00). In the overall adjusted main effect model, intelligibility 
score was associated with a 0.04 point (95% CI: −0.08, −0.01) lower score for every ng/mL 
of PFOA. The associations observed at 38 months between maternal PFAS concentrations 
and MCDI scores also varied by maternal age at delivery. In the overall adjusted main effect 
model, language score was associated with a 1.52 point (95% CI: −11.21, 8.16) lower score 
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for every ng/mL of PFNA. After stratification for maternal age at delivery, 1 ng/mL PFNA 
was associated with a 3.06 point (95% CI: −20.75, −14.62) lower language score among 
daughters of mothers aged < 25, and 14.10 point (95% CI: −27.10, −0.50) lower language 
score among daughters of mothers age between 25 and 30. However, among daughters with 
mothers aged > 30, language score was associated with a 5.62 point (95% CI: −15.20, 26.44) 
higher score for every ng/mL of PFNA. Overall, after stratified for maternal age at delivery, 
most associations between all measured PFAS and language development score were 
negative. Positive and negative associations were seen between measured PFAS and 
intelligibility and communicative scores.
4. Discussion
PFAS exposure could result in important deficits or delays in childhood cognitive 
development, but previous research in large cohorts lacks consistency to draw definitive 
conclusions. Our study examines communication indexes at two time points during early 
childhood that are important periods of communication development. Our study suggests 
that maternal serum concentrations of select PFAS are modestly associated with 
communication development among girls and did not show a consistent pattern of 
association across all measured PFAS and endpoints. Although a direct comparison cannot 
be made due to differences in the items, constructs, and format of the MCDI administered at 
the two time points, we found less apparent associations at 38 months of age when 
compared to findings at 15 months of age. We also observed that the association between 
select maternal PFAS concentrations and communication development varied by maternal 
age at delivery.
Several cohort studies have found differing associations between prenatal PFAS exposure 
and cognitive development in children. Fei and colleagues selected 1400 boy and girl 
children from the Danish National Birth Cohort to assess the association between prenatal 
PFOS and PFOA concentrations in maternal serum samples and developmental milestones 
in the offspring [21]. Motor (gross and fine motor functioning) and mental (cognitive 
functions, language, and social-personal) development of offspring at 6 and 18 months of 
age were measured through maternal reports. Although there appeared to be no evidence that 
prenatal exposure to PFOS or PFOA was associated with overall motor or mental 
development, the study found that offspring of women with higher serum PFOS 
concentrations scored lower on the language component of the assessment at 18 months 
[21]. Compared to serum maternal exposure concentrations in ALSPAC, mean maternal 
concentrations of PFOS and PFOA in plasma were higher in girls in the Danish National 
Birth Cohort, at 35.3 ng/mL (SD: 13.0) and 5.5 ng/mL (SD: 2.6), respectively.
Conversely, Chen and colleagues selected 239 children from the Taiwan Birth Panel to 
evaluate the association between prenatal exposure to PFOS and PFOA and childhood 
neurodevelopment at 2 years of age. The study found a negative association between PFOS 
concentrations in cord blood and overall neurodevelopment, which was measured based on 
combined scores from the cognitive, language, motor, social, and self-help domains of the 
Comprehensive Developmental Inventory for Infant and Toddlers [12]. However, the study 
found a null association between both PFOS and PFOA and the language domain of 
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neurodevelopment specifically. Compared to ALSPAC, mean maternal concentrations of 
PFOS and PFOA were lower in the cord blood samples of the Taiwan Birth Panel, at 7.4 
ng/mL (SD: 2.5) and 2.6 (SD: 2.5), respectively.
In a hospital based birth cohort study (n = 514), Goudarzi and colleagues used data from the 
Hokkaido Study to examine associations between prenatal PFOS and PFOA concentrations 
and neurodevelopment at 6 and 18 months of age using the Mental Developmental Index 
(MDI) and Psychomotor Developmental Index (PDI) from the Bayley Scales of Infant 
Developmental Indices [30]. Although the study did not find any significant associations at 
18 months of age, they found prenatal PFOA exposure to be negatively associated with MDI 
at 6 months of age in females after stratifying for sex. Compared to ALSPAC, median 
maternal serum concentrations of PFOS and PFOA were lower in the samples of the 
Hakkaido Study, at 5.7 ng/mL (95% CI: 4.4–7.4) and 1.2 (SD: 0.8–1.7), respectively.
Our study extends the previous literature by reporting associations between measures of 
language development with PFHxS and PFNA, two compounds not examined in previous 
studies. The concentrations of these chemicals were relatively low in comparison to PFOS 
and PFOA.
Additional research has examined the association between prenatal exposure to PFAS and 
neurodevelopment in school aged children with differing conclusions. Wang and colleagues 
found a negative association between prenatal PFNA exposure and verbal intelligence 
quotient at 8 years of age in the Taiwan Maternal and Infant Cohort Study (TMICS) (n = 
120) [31]. In another study, Vuong and colleagues examined the association between 
prenatal PFAS exposure and executive function at 5 and 8 years of age using data from the 
Health Outcomes and Measures of the Environment Study (n = 256) [32]. Although no 
associations were found with prenatal PFOA exposure, prenatal PFHxS and PFOS exposure 
were found to have a negative association with executive function. Whereas, Stein and 
colleagues found no adverse associations between in utero PFOA exposure and 
neurobehavioral development in a sample of 320 children from the C8 Health Project at 6–
12 years of age [33]. Due to contaminated drinking water, children from this study were 
highly exposure to PFOA with a median maternal concentration of 43.7 ng/mL (interquartile 
range: 11.7–110.8).
In the subset of the ALSPAC cohort studied here, the association between maternal PFAS 
exposure and early communication development at both 15 and 38 months varied by 
mother's age at delivery. It is possible that the influence of maternal age may be related to 
social factors such as differences in the amount of time spent one-on-one or in the types of 
activities older versus younger mothers performed with their children [34]. Several studies 
have reported that quantity of parent reported child-directed speech and a richer language 
experience is associated with language development in children, including language 
processing and vocabulary [35–38]. Socioeconomic status, parental knowledge of child 
development, and social context have been reported to influence the association between 
speech directed to the child and the child's language development [36,38].
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We observed a less apparent association at 38 months when compared to 15 months, 
although direct comparison cannot be made due to the item and overall format differences 
between the two questionnaires. It is possible that earlier in childhood, mothers are more 
central to children's development of language and communication skills. However, as they 
get older, children are exposed to a variety of individuals and experiences, including 
daycare, that may contribute to that development [39]. Center care has been found to have a 
positive influence on cognitive and language development [39]. The additional influences 
during a child's development could be a potential explanation for the less apparent 
association between maternal PFAS concentrations and communication development in the 
sample of mother daughter dyads at 38 months of age when compared to 15 months of age.
The mechanisms behind PFAS' effects on child development and specifically language, are 
not well understood. In toxicologic studies of animals, neurologic and behavioral effects of 
neonatal PFAS exposure have been documented, suggesting that exposure to PFAS during 
critical windows of development can affect brain development [20,40,41]. In mice, in 
addition to behavior changes, such as disruption of habituation, neonatal exposure to PFOS 
and PFOA altered the susceptibility of the cholinergic system, potentially priming the brain 
for cognitive deficits later in life, and led to altered amounts of proteins essential for brain 
development (e.g. CAMKII, GAP-43, synaptophysis and tau) [20,40]. Similar effects were 
also seen in mice after neonatal exposure to PFHxS [41]. Additionally, PFAS may affect 
neurodevelopment through alteration of myelination [42]. In humans, EDCs can alter the 
epigenetics of development and the development of parts of the brain, such as the cerebral 
cortex, possibly leading to deficits in cognitive development [43].
There are potential limitations to the current analyses. Due to PFAS' long half-lives, a one-
time serum sample was used as an indicator of exposure concentrations throughout 
pregnancy [11]. Models were adjusted to control for gestational age at sample collection to 
account for potential differences in PFAS exposure levels during pregnancy. Moreover, 
analyzing data from a population originally selected for an ancillary study may introduce 
bias. However, as previously reported, sample characteristics of mother-daughter dyads in 
the ancillary study were similar to those dyads enrolled in the overall cohort, and linear 
regression models were weighted to account for this sampling scheme (23). Additionally, 
due to the original objectives of the case-control study that provided PFAS concentrations, 
the current study was limited to communication development among girls, and did not 
address any potential associations among PFAS and neurodevelopment in boys. Similar to 
previous investigations, the results did not show a consistent pattern of association either 
across all PFAS measured or across all endpoints [12,21]. The clinical relevance of the effect 
sizes of maternal PFAS concentrations on the daughter's MCDI scores is unknown, however, 
low MCDI scores in early childhood could be indicative of developmental delays [25]. 
Lastly, this study is limited by sample size and the possibility that the findings may be 
explained by chance is an important consideration.
There are several strengths to the current analyses. The ALSPAC dataset includes numerous 
covariates collected under tightly regulated conditions for both mothers and offspring in the 
study. Our study was able to examine development of communication skills at two different 
time points in early childhood, a period close to the onset of vocabulary acquisition and a 
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period of increased mastery of vocabulary and communication skills. The PFAS were 
analyzed using well-characterized methodologies performed by laboratories at the National 
Center of Environmental Health at the CDC [28]. The same methods were used for analysis 
of samples from the 2003–2004 NHANES sample population [3]. Studying health effects of 
PFAS, specifically on neurodevelopment, is an important topic that warrants additional 
research, including PFAS' effects at later time points in childhood, and in boys.
In conclusion, maternal serum concentrations to select PFAS were both positively and 
negatively associated with early communication development among girls, although 
associations were less apparent at 38 months of age compared to 15 months of age. The 
effect between maternal PFAS exposure and communication development varied by 
maternal age at delivery. There was an inconsistent pattern of association across all 
measured PFAS and endpoints.
Acknowledgments
We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting 
them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical 
workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and 
the Wellcome Trust (Grant ref.: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. 
This publication is the work of the authors and they will serve as guarantors for the content of this paper. This 
research was specifically funded by the CDC. The findings and conclusions do not necessarily represent views of 
the CDC. Furthermore, I would like to thank Drs. Antonia M. Calafat and Kayoko Kato (Division of Laboratory 
Sciences, National Center of Environmental Health, CDC) for their role in the laboratory analysis of the samples.
References
1. Health UDo, Services H. Draft Toxicological Profile For Perfluoroalkyls. Agency for Toxic 
Substances and Disease Registry; Atlanta: 2009. 
2. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. Cord serum 
concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to 
weight and size at birth. Environ. Health Perspect. 2007:1670–1676. [PubMed: 18008002] 
3. Calafat AM, Wong L-Y, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the US 
population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–
2004 and comparisons with NHANES 1999–2000. Environ. Health Perspect. 2007:1596–1602. 
[PubMed: 18007991] 
4. von Ehrenstein OS, Fenton SE, Kato K, Kuklenyik Z, Calafat AM, Hines EP. Polyfluoroalkyl 
chemicals in the serum and milk of breastfeeding women. Reprod. Toxicol. 2009; 27(3):239–245. 
[PubMed: 19429402] 
5. Paul AG, Jones KC, Sweetman AJ. A first global production, emission, and environmental inventory 
for perfluorooctane sulfonate. Environ. Sci. Technol. 2008; 43(2):386–392.
6. Xie S, Lu Y, Wang T, Liu S, Jones K, Sweetman A. Estimation of PFOS emission from domestic 
sources in the eastern coastal region of China. Environ. Int. 2013; 59:336–343. [PubMed: 
23892226] 
7. Xie S, Wang T, Liu S, Jones KC, Sweetman AJ, Lu Y. Industrial source identification and emission 
estimation of perfluorooctane sulfonate in China. Environ. Int. 2013; 52:1–8. [PubMed: 23266910] 
8. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their 
derivatives. Toxicol. Appl. Pharmacol. 2004; 198(2):231–241. [PubMed: 15236955] 
9. Harbison, RD., Bourgeois, MM., Johnson, GT. Hamilton and Hardy's Industrial Toxicology. John 
Wiley & Sons; 2015. 
10. Wang Z, Cousins IT, Scheringer M, Hungerbühler K. Fluorinated alternatives to long-chain 
perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their 
potential precursors. Environ. Int. 2013; 60:242–248. [PubMed: 24660230] 
Jeddy et al. Page 9
Early Hum Dev. Author manuscript; available in PMC 2018 June 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
11. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. Half-life of 
serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate 
in retired fluorochemical production workers. Environ. Health Perspect. 2007:1298–1305. 
[PubMed: 17805419] 
12. Chen M-H, Ha E-H, Liao H-F, Jeng S-F, Su Y-N, Wen T-W, et al. Perfluorinated compound levels 
in cord blood and neurodevelopment at 2 years of age. Epidemiology. 2013; 24(6):800–808. 
[PubMed: 24036611] 
13. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM. Exposure to polyfluoroalkyl 
chemicals and attention deficit/hyperactivity disorder in US children 12–15 years of age. Environ. 
Health Perspect. 2010; 118(12):1762. [PubMed: 20551004] 
14. Ribas-Fito N, Sala M, Kogevinas M, Sunyer J. Polychlorinated biphenyls (PCBs) and neurological 
development in children: a systematic review. J. Epidemiol. Community Health. 2001; 55(8):537–
546. [PubMed: 11449010] 
15. Huisman M, Koopman-Esseboom C, Fidler V, Hadders-Algra M, van der Paauw CG, Tuinstra 
LGT, et al. Perinatal exposure to polychlorinated biphenyls and dioxins and its effect on neonatal 
neurological development. Early Hum. Dev. 1995; 41(2):111–127. [PubMed: 7601016] 
16. Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV, Silva MJ, et al. Endocrine disruptors and 
childhood social impairment. Neurotoxicology. 2011; 32(2):261–267. [PubMed: 21182865] 
17. Birnbaum LS. Developmental effects of dioxins and related endocrine disrupting chemicals. 
Toxicol. Lett. 1995; 82:743–750. [PubMed: 8597137] 
18. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for 
reproductive tract alterations and obesity later in life. Am. J. Clin. Nutr. 2011; 94(6 Suppl):1939S–
1942S. [PubMed: 22089436] 
19. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. Perfluorooctane sulfonate (PFOS) 
and related perfluorinated compounds in human maternal and cord blood samples: assessment of 
PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspect. 
2004:1204–1207. [PubMed: 15289168] 
20. Johansson N, Eriksson P, Viberg H. Neonatal exposure to PFOS and PFOA in mice results in 
changes in proteins which are important for neuronal growth and synaptogenesis in the developing 
brain. Toxicol. Sci. 2009; 108(2):412–418. [PubMed: 19211617] 
21. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and 
perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. 
Environ. Health Perspect. 2008; 116(10):1391–1395. [PubMed: 18941583] 
22. Roth N, Wilks M. Neurodevelopmental and neurobehavioural effects of polybrominated and 
perfluorinated chemicals: a systematic review of the epidemiological literature using a quality 
assessment scheme. Toxicol. Lett. 2014; 230(2):271–281. [PubMed: 24583043] 
23. Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, et al. Maternal 
concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in 
British girls. Environ. Health Perspect. 2012; 120(10):1432–1437. [PubMed: 22935244] 
24. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Smith GD, et al. Cohort profile: the 
Avon Longitudinal Study of Parents and hildren: ALSPAC mothers cohort. Int. J. Epidemiol. 2013; 
42(1):97–110. [PubMed: 22507742] 
25. Heilmann J, Weismer SE, Evans J, Hollar C. Utility of the MacArthur—Bates Communicative 
Development Inventory in identifying language abilities of late-talking and typically developing 
toddlers. Am. J. Speech Lang. Pathol. 2005; 14(1):40–51. [PubMed: 15966111] 
26. Luyster R, Lopez K, Lord C. Characterizing communicative development in children referred for 
autism spectrum disorders using the MacArthur-Bates Communicative Development Inventory 
(CDI). J. Child Lang. 2007; 34(03):623–654. [PubMed: 17822142] 
27. Luyster R, Qiu S, Lopez K, Lord C. Predicting outcomes of children referred for autism using the 
MacArthur–Bates Communicative Development Inventory. J. Speech Lang. Hear. Res. 2007; 
50(3):667–681. [PubMed: 17538108] 
28. Kuklenyik Z, Needham LL, Calafat AM. Measurement of 18 perfluorinated organic acids and 
amides in human serum using on-line solid-phase extraction. Anal. Chem. 2005; 77(18):6085–
6091. [PubMed: 16159145] 
Jeddy et al. Page 10
Early Hum Dev. Author manuscript; available in PMC 2018 June 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
29. Kleinbaum, DG., Kupper, LL., Morgenstern, H. Epidemiologic Research: Principles and 
Quantitative Methods. John Wiley & Sons; 1982. 
30. Goudarzi H, Nakajima S, Ikeno T, Sasaki S, Kobayashi S, Miyashita C, et al. Prenatal exposure to 
perfluorinated chemicals and neurodevelopment in early infancy: the Hokkaido Study. Sci. Total 
Environ. 2016; 541:1002–1010. [PubMed: 26473702] 
31. Wang Y, Rogan WJ, Chen H-Y, Chen P-C, Su P-H, Chen H-Y, et al. Prenatal exposure to 
perfluroalkyl substances and children's IQ: the Taiwan maternal and infant cohort study. Int. J. 
Hyg. Environ. Health. 2015; 218(7):639–644. [PubMed: 26205657] 
32. Vuong AM, Yolton K, Webster GM, Sjödin A, Calafat AM, Braun JM, et al. Prenatal 
polybrominated diphenyl ether and perfluoroalkyl substance exposures and executive function in 
school-age children. Environ. Res. 2016; 147:556–564. [PubMed: 26832761] 
33. Stein, CR., Savitz, DA., Bellinger, DC. Epidemiology. Vol. 24. Cambridge, Mass: 2013. 
Perfluorooctanoate (PFOA) and neuropsychological outcomes in children; p. 590
34. Coon H, Fulker DW, DeFries J, Plomin R. Home environment and cognitive ability of 7-year-old 
children in the Colorado Adoption Project: genetic and environmental etiologies. Dev. Psychol. 
1990; 26(3):459.
35. Weisleder A, Fernald A. Talking to children matters early language experience strengthens 
processing and builds vocabulary. Psychol. Sci. 2013; 24(11):2143–2152. [PubMed: 24022649] 
36. Rowe ML. Child-directed speech: relation to socioeconomic status, knowledge of child 
development and child vocabulary skill. J. Child Lang. 2008; 35(01):185–205. [PubMed: 
18300434] 
37. Rowe ML. A longitudinal investigation of the role of quantity and quality of child-directed speech 
in vocabulary development. Child Dev. 2012; 83(5):1762–1774. [PubMed: 22716950] 
38. Ramírez-Esparza N, García-Sierra A, Kuhl PK. Look who's talking: speech style and social context 
in language input to infants are linked to concurrent and future speech development. Dev. Sci. 
2014; 17(6):880–891. [PubMed: 24702819] 
39. Health NIoC, Network HDECCR. The relation of child care to cognitive and language 
development. Child Dev. 2000:960–980. [PubMed: 11016559] 
40. Johansson N, Fredriksson A, Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) 
and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. 
Neurotoxicology. 2008; 29(1):160–169. [PubMed: 18063051] 
41. Viberg H, Lee I, Eriksson P. Adult dose-dependent behavioral and cognitive disturbances after a 
single neonatal PFHxS dose. Toxicology. 2013; 304:185–191. [PubMed: 23287389] 
42. Fernandez M, Paradisi M, D'Intino G, Del Vecchio G, Sivilia S, Giardino L, et al. A single prenatal 
exposure to the endocrine disruptor 2, 3, 7, 8-tetrachlorodibenzop- dioxin alters developmental 
myelination and remyelination potential in the rat brain. J. Neurochem. 2010; 115(4):897–909. 
[PubMed: 20807317] 
43. Fudvoye J, Bourguignon J-P, Parent A-S. Endocrine-disrupting chemicals and human growth and 
maturation: a focus on early critical windows of exposure. Vitam. Horm. 2014; 94:1–25. [PubMed: 
24388185] 
Jeddy et al. Page 11
Early Hum Dev. Author manuscript; available in PMC 2018 June 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Jeddy et al. Page 12
Table 1
Sample characteristics for mothers and daughters enrolled in ALSPACa with maternal serum PFASb 
concentrations and ALSPAC-adapted MCDIc sub-scores at 15 or 38 months of age (n = 432).
N Median IQRd
Maternal PFAS exposure
  Perfluorooctane sulfonate (PFOS) (ng/mL) 432 19.8 15.0, 24.95
  Perfluorooctanoate (PFOA) (ng/mL) 432 3.7 2.8, 4.8
  Perfluorohexane sulfonate (PFHxS) (ng/mL) 432 1.6 1.2, 2.2
  Perfluorononanoate (PFNA) (ng/mL) 432 0.5 0.4, 0.7
Adapted MCDI scores at 15 months
  Nonverbal communication score 419 15.0 13.0, 17.0
  Verbal comprehension score 419 10.0 8.0, 12.0
  Vocabulary comprehension and production score 419 87.0 62.0, 124.0
  Social development score 420 18.0 14.5, 22.0
Adapted MCDI scores at 38 months
  Language score 400 314.0 298.5, 322.0
  Intelligibility score 404 6.0 6.0,6.0
  Communicative ability score 403 5.0 4.0, 6.0
Covariates
  Maternal CCEIe score at 8 months 405 8.0 5.0, 13.0
Gestational age at sample collection, weeks 432 15.0 10.0, 28.0
N %
Maternal education
  Less than O level 83 19.21
  O level 138 31.94
  Greater than O level 196 45.37
  Missing 15 3.47
Maternal age at delivery
  < 25 years 88 20.37
  25–29 years 163 37.73
  ≥ 29 years 181 41.9
Maternal alcohol consumptionf
  Yes 223 51.62
  No 192 44.44
  Missing 17 3.94
Maternal smoking statusf
  Yes 98 22.69
  No 319 73.84
  Missing 15 3.47
Parity
  0 205 47.45
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N Median IQRd
  1+ 208 48.15
  Missing 19 4.4
a
Avon Longitudinal Study of Parents and Children.
b
Perfluoroalkyl substances.
c
MacArthur Communicative Development Inventories.
d
Interquartile range.
e
Crown-Crisp Experiential Index.
f
During first three months of pregnancy.
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